chr16-29901635-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_181718.4(ASPHD1):c.664C>T(p.Arg222Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,568,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_181718.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPHD1 | NM_181718.4 | c.664C>T | p.Arg222Trp | missense_variant | 1/3 | ENST00000308748.10 | NP_859069.2 | |
ASPHD1 | XM_017023107.2 | c.211C>T | p.Arg71Trp | missense_variant | 2/4 | XP_016878596.1 | ||
ASPHD1 | XR_007064864.1 | n.1148C>T | non_coding_transcript_exon_variant | 1/4 | ||||
ASPHD1 | XR_007064865.1 | n.1148C>T | non_coding_transcript_exon_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPHD1 | ENST00000308748.10 | c.664C>T | p.Arg222Trp | missense_variant | 1/3 | 1 | NM_181718.4 | ENSP00000311447.5 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000114 AC: 24AN: 209812Hom.: 0 AF XY: 0.000123 AC XY: 14AN XY: 114260
GnomAD4 exome AF: 0.0000184 AC: 26AN: 1416738Hom.: 0 Cov.: 33 AF XY: 0.0000227 AC XY: 16AN XY: 703836
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.664C>T (p.R222W) alteration is located in exon 1 (coding exon 1) of the ASPHD1 gene. This alteration results from a C to T substitution at nucleotide position 664, causing the arginine (R) at amino acid position 222 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at